Midpoint Transverse Process to Pleura (MTP) Block vs Erector Spinae Plane (ESP) Block for Acute Herpes Zoster (HZ) Pain

Sponsor
Tanta University
Study ID
NCT07732556
Status
Recruiting
Apply to this trial

Conditions

  • Acute Herpes Zoster
  • Erector Spinae Plane Block
  • Midpoint Transverse Process to Pleura Block
  • Pain

Eligibility Criteria

Sex
ALL
Age
21 Years - 60 Years
Healthy Volunteers
Not accepted

Interventions

  • Midpoint transverse process to pleura block — OTHER
    Patients will receive ultrasound-guided midpoint transverse process to pleura block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.
  • Erector spinae plane block — OTHER
    Patients will receive ultrasound -guided erector spinae plane block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.

Study Details

The aim of this study is to compare the analgesic efficacy and safety of ultrasound-guided midpoint transverse process block versus ultrasound-guided erector spinae plane block in patients suffering from thoracic herpes zoster pain.

Key Dates

First listed
Jul 29, 2026
Start date
Jul 1, 2026
Status verified
Jul 2026
Primary completion
Jun 1, 2027
Completion
Jun 1, 2027

Study Design

Enrollment
90 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Other: Group MTP
    Patients will receive ultrasound-guided midpoint transverse process to pleura block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.
  • Other: Group ESP
    Patients will receive ultrasound -guided erector spinae plane block using 10 mL 0.25% bupivacaine + 40 mg methylprednisolone.

Primary Outcome Measure

Incidence of post-herpatic neuralgia [ Time Frame: After 12 weeks of block ]

Central Contacts

Related Studies